On the days 21, 28, 35 and 42 after the first immunization, the levels of anti-PCV2 antibodies in TB-Cap-GM-CSF and TB-Cap-CD154 groups were significantly higher than that in the TB-Cap group (p < 0.0001). This evidence concerns the gene CSF2 and tuberculosis.